Puillary Responses as a risk and staging biomarker of preclinical Alzheimer's disease
Study Name | Puillary Responses as a risk and staging biomarker of preclinical AD |
Principal Investigator(s) | Eric Granholm, Ph.D. & Mark Bondi, Ph.D. |
Required Diagnosis | Normal Cognition, Mild Cognitive Impairment (MCI), Alzheimer's disease (AD) |
Age | 60-85 |
Length | 1-2 days (~8 hrs); 1-month pupillometry follow up is optional; ask ONLY cognitively NORMAL to come back for MRIs in 1 and 3 years, but no involvement between those times |
Lumbar Puncture | Yes |
MRI | Yes |
Amyloid PET | No |
Tau PET | No |
Compensation | Unknown |
Contact | participate@ucsd.edu |